Accuracy of an administrative database for pancreatic cancer by international classification of disease 10th codes: A retrospective large-cohort study

doi:10.3748/wjg.v25.i37.5619

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 25, Issue 37

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8381)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-6) series.

Item

Count

PDF

470

WORD

288

HTML

3800

Figures (1-1)

385

Tables (1-6)

314

Sum=5257

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1066

Download

2058

Sum=3124

Oct 7, 2019 (publication date) through Jan 4, 2025

Times Cited of This Article

Times Cited (14)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

World J Gastroenterol. Oct 7, 2019; 25(37): 5619-5629
Published online Oct 7, 2019. doi: 10.3748/wjg.v25.i37.5619

Table 1 Diagnostic criteria of pancreatic cancer

Diagnostic criteria	Methods	Positive finding
Definite criteria
Pathologic analysis	Endoscopy, ERCP, EUS-FNA, Surgery	Adenocarcinoma Mucinous carcinoma Adenosquamous carcinoma Other malignant neoplasm
Possible criteria
Imaging finding	CT, MRI, ERCP, MRCP, EUS, endoscopy, PET	Focal hypo-attenuated lesion Pancreatic duct dilation Distal pancreatic parenchymal atrophy Involvement of the surrounding vascular structures or other organs
Clinical features	Medical record	Clinical courses compatible with PC
Tumor marker	CA19-9	> 100 U/mL
	αFP	To exclude other malignancies including hepatocellular carcinoma

CT: Positron emission tomography; MRI: Magnetic resonance imaging; ERCP: Endoscopic retrograde cholangiopancreatography; MRCP: Magnetic resonance cholangiopancreatography; EUS: Endoscopic ultrasound; PET: Positron emission tomography; FNA: Fine needle aspiration; CA19-9: Carbohydrate antigen 19-9; αFP: α-fetoprotein; PC: Pancreatic cancer.

Citation: Hwang YJ, Park SM, Ahn S, Lee JC, Park YS, Kim N. Accuracy of an administrative database for pancreatic cancer by international classification of disease 10^th codes: A retrospective large-cohort study. World J Gastroenterol 2019; 25(37): 5619-5629
URL: https://www.wjgnet.com/1007-9327/full/v25/i37/5619.htm
DOI: https://dx.doi.org/10.3748/wjg.v25.i37.5619